On ECHEMI
Home > Drugs > Erlotinib hydrochloride Registered Holders
Erlotinib hydrochloride structure

Erlotinib hydrochloride structure

Erlotinib hydrochloride

Erlotinib hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM.

Find 38 Related Holders

CDYMAX (INDIA) PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
HIKMA PHARMACEUTICALS PLC
United States United States

API Registration Country

API Active
RELIANCE LIFE SCIENCES PVT LTD
United States United States

API Registration Country

API Active
LAURUS LABS LTD
United States United States

API Registration Country

API Active
HETERO LABS LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
CAMBREX CHARLES CITY INC
United States United States

API Registration Country

API Active
INTAS PHARMACEUTICALS LTD
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    CHINUBHAI CENTER - OFF. NEHRU BRIDGE, S/N ASHRAM ROAD - GUJARAT, EXTERIOR - EX
NATCO PHARMA LTD
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    ROAD NR 2, EXTERIOR - EX
HETERO LABS LIMITED
India India

API Registration Country

API Active
  • Founded in:

    1989-03-10 00:00:00
  • Country:

    India India
  • Address:

    #7-2-A2, Industrial Estate, Sanath Nagar, Sanathnagar I E Balanagar Hyderabad TG 500018 IN
  • Registered Funds:

    2.8 billion INR
  • Email:

Recommended Suppliers of Erlotinib hydrochloride
View 174 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.